NCT05753774 Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders
| NCT ID | NCT05753774 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Biao Zou |
| Condition | Functional Gastrointestinal Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-08-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-08-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Safety and efficacy of FMT in Pediatric Functional Gastrointestinal Disorders
Eligibility Criteria
Inclusion Criteria: * The diagnosis and classification of patients with FGIDs were in accordance with the ROME IV criteria for children Exclusion Criteria: * organic gastrointestinal disease (as established by medical history, blood routine, biochemistry, c-reaction protein, erythrocyte sedimentation rate, and fecal routine examinations.) * other chronic disease * growth failure
Contact & Investigator
Zhihua Huang
STUDY DIRECTOR
Tongji Hospital
Frequently Asked Questions
Who can join the NCT05753774 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 15 Years, studying Functional Gastrointestinal Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05753774 currently recruiting?
Yes, NCT05753774 is actively recruiting participants. Contact the research team at 464021552@qq.com for enrollment information.
Where is the NCT05753774 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT05753774 clinical trial?
NCT05753774 is sponsored by Biao Zou. The principal investigator is Zhihua Huang at Tongji Hospital. The trial plans to enroll 100 participants.